Pulmotect, a Houston-area biotech, has a drug that could rev up a patient's immune system in the lungs. It just received a $3 million grant from the NIH to learn whether its drug prevents pneumonia in cancer patients.
It’s no surprise that scientists are finding it tougher and tougher to get funding for their research – thanks largely, of course, to NIH funding and budget cuts. A recent NPR piece detailed the booms and busts in research funding, following Baylor College of Medicine associate professor Robert Waterland’s travails with finding funding for his obesity […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.